$9.01
1.21% yesterday
Nasdaq, Jun 27, 10:13 pm CET
ISIN
US92556V1061
Symbol
VTRS

Viatris Stock price

$9.01
+0.41 4.77% 1M
-3.47 27.80% 6M
-3.44 27.63% YTD
-1.47 14.03% 1Y
-2.06 18.61% 3Y
-6.98 43.65% 5Y
-58.62 86.68% 10Y
-10.07 52.78% 20Y
Nasdaq, Closing price Fri, Jun 27 2025
-0.11 1.21%
ISIN
US92556V1061
Symbol
VTRS
Sector
Industry

Key metrics

Basic
Market capitalization
$10.6b
Enterprise Value
$23.9b
Net debt
$13.3b
Cash
$849.5m
Shares outstanding
1.2b
Valuation (TTM | estimate)
P/E
negative | 3.99
P/S
0.74 | 0.75
EV/Sales
1.67 | 1.70
EV/FCF
12.91
P/B
0.68
Dividends
DPS
$0.48
Yield 1Y | 5Y
5.33% | 2.74%
Growth 1Y | 5Y
0.00% | -
Payout 1Y | 3Y
-90.57% | 117.07%
Increased
0 Years
Financials (TTM | estimate)
Revenue
$14.3b | $14.1b
EBITDA
$4.4b | $4.1b
EBIT
$1.5b
Net Income
$-3.8b | $2.7b
Free Cash Flow
$1.9b
Growth (TTM | estimate)
Revenue
-6.71% | -4.49%
EBITDA
4.91% | -11.84%
EBIT
2.71%
Net Income
-6,655.97% | 522.14%
Free Cash Flow
-7.44%
Margin (TTM | estimate)
Gross
40.69%
EBITDA
30.64% | 29.23%
EBIT
10.63%
Net
-26.45% | 19.02%
Free Cash Flow
12.92%
Financial Health
Equity Ratio
44.90%
Return on Equity
-3.40%
ROCE
4.65%
ROIC
4.28%
Debt/Equity
0.91
More
EPS
$-3.18
FCF per Share
$1.56
Short interest
4.18%
Employees
33.00k
Rev per Employee
$450.00k
Show more

Is Viatris a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,914 stocks worldwide.

Viatris Stock Analysis

Unlock Scores for Free

Analyst Opinions

14 Analysts have issued a Viatris forecast:

2x Buy
14%
7x Hold
50%
5x Sell
36%

Analyst Opinions

14 Analysts have issued a Viatris forecast:

Buy
14%
Hold
50%
Sell
36%

Financial data from Viatris

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
14,330 14,330
7% 7%
100%
- Direct Costs 8,500 8,500
2% 2%
59%
5,831 5,831
12% 12%
41%
- Selling and Administrative Expenses 3,480 3,480
20% 20%
24%
- Research and Development Expense 827 827
1% 1%
6%
4,391 4,391
5% 5%
31%
- Depreciation and Amortization 2,867 2,867
6% 6%
20%
EBIT (Operating Income) EBIT 1,524 1,524
3% 3%
11%
Net Profit -3,790 -3,790
6,656% 6,656%
-26%

In millions USD.

Don't miss a Thing! We will send you all news about Viatris directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Viatris Stock News

Neutral
PRNewsWire
2 days ago
MR-141 Met Primary And All Secondary Endpoints, Demonstrating Rapid And Sustained Improvement In Near Visual Acuity Without Compromising Distance Vision Safety Profile Consistent With Previous Clinical Trials And No Treatment-Related Serious Adverse Events Reported In This Study Targeting Application To U.S. FDA In Second Half of 2025 PITTSBURGH , June 26, 2025 /PRNewswire/ -- Viatris Inc. (Nas...
Neutral
PRNewsWire
16 days ago
PITTSBURGH , June 12, 2025 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS) will report second quarter 2025 financial results on Thursday, August 7, 2025. Company executives will host a webcast at 8:30 a.m.
Neutral
GlobeNewsWire
18 days ago
NEW YORK, June 10, 2025 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Viatris Inc. (NASDAQ: VTRS) breached their fiduciary duties to shareholders.
More Viatris News

Company Profile

Viatris, Inc. engages in the commercialization and manufacturing of pharmaceutical products. It also offers support services such as diagnostic clinics, educational seminars, and digital tools. The company was founded on February 14, 2019 and is headquartered in Canonsburg, PA.

Head office United States
CEO Scott Smith
Employees 33,000
Founded 2019
Website www.viatris.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today